#Thiel-backed psychedelic drugmaker valued at .2B in Nasdaq debut

#Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut

“#Thiel-backed psychedelic drugmaker valued at $3.2B in Nasdaq debut” Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, surged 40 percent in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion. The Berlin-based biotech startup, which is exploring the use of psychedelic treatments for mental illnesses,…

Read More